Tag Archives: US Food and Drug Administration

Stem Cell Research Saves Diabetes Patient’s Leg From Amputation

Victory for Adult Stem Cell Research- Saves a Man’s Leg
Tom Fisher already had his  right leg amputated due to complications from Diabetes and he was in danger of losing his left leg as well.  However, stem cell research in the form of Adult Stem Cells has saved his leg from amputation and have healed all his […]

US Patients Battle the FDA Over Use of Their Own Cells

American Doctors and Patients Challenge the FDA to Save Lives Rather Than Allow Patients to Needlessly Die
A couple of weeks ago, the American Stem Cell Therapy Association (ASCTA) was formed by a group of doctors, not to debate the pros and cons of embryonic stem cell research and adult stem cell research, but to […]

Doctors Organization Publishes U.S.’s First Adult Stem Cell Guidelines

US Doctors Group Organize to Challenge the FDA
In a bold move that is sure to shake the foundations of the United States FDA, a group of American doctors have published a set of strict clinical guidelines that will allow US doctors to treat patients with their own Adult Stem Cells.
Your Own Stem Cells Are Not […]

Embryonic Stem Cells: USA, Stem Cell Therapy to be Performed on Humans for the First Time

Image by Getty Images via Daylife

A stem cell injection bound to create a stir is about to take place. For the first time ever the Food and Drug Administration (FDA) (the United States government agency regulating scientific research) has authorized a company to transfer embryonic stem cells to patients paralyzed by spinal trauma. It will be the first procedure of its kind after newly inaugurated President Barack Obama promised to remove limits on financing for embryonic stem cell research imposed by George Bush in 2001.

The details of the initiative are beginning to take form, explained Thomas Okarma,
Read More…

Why Embryonic Stem Cells Are Obsolete

Image via Wikipedia

Scientists may be growing impatient, but President Obama has been rightly taking his time in addressing a campaign promise to lift the ban on federal funding for research using new lines of stem cells to be taken from human embryos. Even for strong backers of embryonic stem cell research, the decision is no longer as self-evident as it was, because there is markedly diminished need for expanding these cell lines for either patient therapy or basic research. In fact, during the first six weeks of Obama’s term, several events reinforced the notion that embryonic stem cells, once
Read More…